This webinar covers the purpose of clinical pharmacology studies in drug development. Generally, clinical pharmacology studies are designed to gain understanding regarding the safety, pharmacokinetics (PK), pharmacodynamics (PD), drug interactions, and PK/PD in special populations of new chemical entities (NCEs) or biologics.
At the end of this webinar attendees should have a better understanding of:
- Types and objectives of clinical pharmacology studies
- Scope and significance of clinical pharmacology studies
- Why we need clinical pharmacology studies
Meet the Speaker
David Y. Mitchell, PhD
Chief Scientific Officer
Dr. Mitchell has more than 28 years of leadership experience in clinical pharmacology and pharmacokinetics (PK). His focus is on strategic drug development, protocol design and planning, clinical and nonclinical data analysis/simulation/interpretation, and clinical pharmacology representation at regulatory meetings.